Search clinical trials for: Short-acting beta 2-adrenergic agonist (SABA)
Total 7598 results
-
NovartisCompleted
-
GlaxoSmithKlineCompletedAsthmaUnited States, Canada, France, Germany, United Kingdom, Australia
-
Novartis PharmaceuticalsSchering-PloughCompletedAsthmaRussian Federation, United Kingdom, Germany, Spain, Czech Republic, Israel, Poland, South Africa, Belgium, Hungary
-
NovartisSchering-PloughCompletedCOPDFrance, Germany, Belgium, Italy, Turkey, Hungary, Argentina, Peru, United Kingdom, South Africa, Latvia, Lithuania, Romania, Chile, Ireland, Norway, Poland
-
University of Tennessee Graduate School of MedicineMylan Pharmaceuticals IncRecruiting
-
AstraZenecaTerminatedAsthmaGermany, Spain, United Kingdom, Korea, Republic of, Canada, Poland, Australia, Taiwan, Hungary, Ukraine
-
Henning BundgaardCompletedChronic Heart Failure With Reduced Ejection Fraction (HFrEF)Australia, Denmark
-
Aaron CypessNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Completed
-
Koneksa HealthCompleted
-
Yonsei UniversityActive, not recruitingPatients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking AnticholinergicsKorea, Republic of
-
University Hospital, Basel, SwitzerlandCompletedThermogenesisSwitzerland
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
Velicept Therapeutics, Inc.CompletedHealthy Subjects, Overactive Bladder
-
AstraZenecaCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAsthmaUnited States, Canada, Czechia, Hungary, Poland, Russian Federation, South Africa, Thailand, Ukraine
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAsthmaUnited States, Australia, Bulgaria, Canada, Croatia, Germany, Greece, Hungary, Ireland, Israel, New Zealand, Poland, Romania, Russian Federation, Serbia, South Africa, Spain, Ukraine, United Kingdom
-
Boryung Pharmaceutical Co., LtdCompletedA Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.Overactive Bladder | Benign Prostatic Hyperplasia (BPH)Korea, Republic of
-
Teva Branded Pharmaceutical Products R&D, Inc.PPDCompletedAsthmaUnited States, Bulgaria, Croatia, Hungary, Israel, Poland, Serbia, Spain, Ukraine
-
Ottawa Heart Institute Research CorporationCompletedAcute Coronary Syndrome | Pulmonary Edema | Cardiogenic Shock | Low Cardiac Output SyndromeCanada
-
GlaxoSmithKlineCompletedOveractive BladderUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Greece, Czechia
-
Parc de Salut MarCompletedHealthy VolunteersSpain
-
University of CopenhagenCompleted
-
Novartis PharmaceuticalsPacira Pharmaceuticals, IncCompletedChronic Obstructive Pulmonary DiseaseSwitzerland
-
DeyCompleted
-
Hospital KemamanCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Catholic University, ItalyCompleted
-
GlaxoSmithKlineCompletedOveractive BladderGermany, Taiwan, Netherlands, Spain, Australia, Korea, Republic of, Latvia, Argentina, Slovenia, Finland, France, South Africa, Poland, New Zealand
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAsthmaUnited States, Canada, Czechia, Hungary, Poland, Russian Federation, South Africa, Ukraine
-
NovartisPacira Pharmaceuticals, IncCompleted
-
Johannes Gutenberg University MainzAstraZenecaCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
US Department of Veterans AffairsCompleted
-
Vanderbilt University Medical CenterTerminatedDelirium | Respiratory FailureUnited States
-
Region SkaneLund UniversityRecruiting
-
Kern Medical CenterUnknown
-
Brigham and Women's HospitalCompleted
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseasePoland